National Coalition of STD Directors Warns of Bicillin L-A Shortage
By Physician’s Briefing Staff HealthDay Reporter
MONDAY, Dec. 4, 2023 -- In a survey from the National Coalition of STD Directors conducted in early November, 46 percent of sexual health clinics said they had tried to order Bicillin L-A only to find that it was unavailable. This comes as syphilis cases surge across America.
Early in November, the U.S. Centers for Disease Control and Prevention sounded the alarm on the disease, noting that rates of congenital syphilis soared 10-fold between 2012 and 2022. In 2022, more than 3,700 babies across the United States were born with syphilis, the CDC said.
Bicillin L-A is made by Pfizer Inc., which in June alerted the U.S. Food and Drug Administration of a shortage that the company predicts may last until mid-2024. The new survey confirms that Bicillin L-A is in short supply nationwide. The group sent its survey to 136 state and local health departments and 151 sexual health clinics in early November.
According to the results of the survey, respondents in 13 different states and one Indian Health Services agency said they had received reports of at least one pregnant woman who had been unable to receive Bicillin L-A; nearly half (46 percent) of clinics said they had had difficulties getting Bicillin L-A, a increase from the 40 percent of clinics who had not been able to access the drug when a prior survey was conducted in August; and more than two-thirds (68 percent) of health department specialists believe shortages will cause syphilis cases to rise even higher in their jurisdictions.
There is a second-line treatment, doxycycline, which patients can use if Bicillin L-A is not available. But treatment can take a month, and severe side effects can occur. In the new survey, 36 percent of clinics said they had had a patient who could not complete their full course of doxycycline. The CDC has already advised that to preserve supply, doctors use Bicillin L-A only for cases of congenital syphilis and give doxycycline to all other patients.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Recommended Treatment for STIs More Likely in Public Versus Private Health Care Settings
TUESDAY, April 30, 2024 -- Individuals seen for sexually transmitted infections (STIs) by clinicians in a private U.S. health care setting are less likely to receive recommended...
Doctors Seeing More Atypical, Severe Symptoms in Patients With Syphilis
MONDAY, April 29, 2024 -- Physicians are increasingly seeing cases of syphilis that do not present with typical symptoms, such as rash or skin ulcers, according to a new report...
2016 to 2022 Saw Increase in Rate of Maternal Syphilis
TUESDAY, Feb. 13, 2024 -- There was an increase in maternal syphilis rates in women giving birth in the United States from 2016 to 2022, according to a February data brief...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.